Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 7/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.57 |
| ▸ | APP | P05067 | 3/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | PI4KA | P42356 | 1/20 | 0.41 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24368479 | 0.98 | ESR1 (0.55) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368438 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368443 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368439 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368462 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368640 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24369522 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368444 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368416 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 | |
| SCHEMBL24368419 | 0.89 | APP (0.60) | ESR1ESR2APPHSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127277-A1 | ORGANIC COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME | DONGJIN SEMICHEM CO., LTD. (KR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127277-A1 | ORGANIC COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME | CAPG, CAPZA1, OCIAD1 | ESR1 2033/4885ESR2 2183/4885APP 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.